| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/01/2023 | DBV Technologies S.A. | DBVT | Purchase | | 15k | $1.62 | $24.3k | | 08/01/2023 |
| 07/06/2022 | Aceragen, Inc. | IDRA | Grant | Stock Option (Right to Buy) | 66.5k | $0.43 | $28.8k | | 07/06/2022 |
| 06/07/2022 | ACADIA PHARMACEUTICALS INC | ACAD | Grant | Restricted Stock Units | 8.6k | $0.00 | $0 | | 06/07/2022 |
| 06/07/2022 | ACADIA PHARMACEUTICALS INC | ACAD | Grant | Director Stock Options (Right to Buy) | 14.4k | $18.27 | $262.5k | | 06/07/2022 |
| 04/01/2022 | Aceragen, Inc. | IDRA | Grant | Stock Option (Right to Buy) | 41.5k | $0.54 | $22.2k | | 04/01/2022 |
| 01/24/2022 | Aceragen, Inc. | IDRA | Grant | Stock Option (Right to Buy) | 25k | $0.57 | $14.4k | | 01/24/2022 |
| 09/30/2021 | KalVista Pharmaceuticals, Inc. | KALV | Grant | Director Stock Option (Right to Buy) | 10k | $17.45 | $174.5k | | 09/30/2021 |
| 07/08/2021 | Aceragen, Inc. | IDRA | Grant | Stock Option (Right to Buy) | 66.5k | $1.11 | $73.8k | | 07/08/2021 |
| 06/22/2021 | ACADIA PHARMACEUTICALS INC | ACAD | Grant | Restricted Stock Units | 6.4k | $0.00 | $0 | | 06/22/2021 |
| 06/22/2021 | ACADIA PHARMACEUTICALS INC | ACAD | Grant | Director Stock Options (Right to Buy) | 11.6k | $24.88 | $289.5k | | 06/22/2021 |
| 06/18/2021 | Aceragen, Inc. | IDRA | Purchase | Common Stock | 50k | $1.19 | $59.5k | | 06/18/2021 |
| 06/10/2021 | DBV Technologies S.A. | DBVT | Purchase | Warrant (right to buy) | 6.8k | $7.12 | $48.7k | | 06/10/2021 |
| 03/05/2021 | Aceragen, Inc. | IDRA | Purchase | Common Stock | 10k | $3.90 | $39k | | 03/05/2021 |
| 01/04/2021 | Aceragen, Inc. | IDRA | Grant | Stock Option (Right to Buy) | 200k | $4.02 | $804k | | 01/04/2021 |
| 10/01/2020 | KalVista Pharmaceuticals, Inc. | KALV | Grant | Director Stock Option (right to buy) | 7k | $12.88 | $90.2k | | 10/01/2020 |
| 10/01/2020 | KalVista Pharmaceuticals, Inc. | KALV | Grant | Director Stock Option (right to buy) | 7k | $12.88 | $90.2k | | 10/01/2020 |
| 06/23/2020 | ACADIA PHARMACEUTICALS INC | ACAD | Grant | Director Stock Options (Right to Buy) | 5.6k | $52.73 | $294.2k | | 06/23/2020 |
| 06/23/2020 | ACADIA PHARMACEUTICALS INC | ACAD | Grant | Restricted Stock Units | 3.1k | $0.00 | $0 | | 06/23/2020 |
| 09/27/2019 | KalVista Pharmaceuticals, Inc. | KALV | Purchase | Common Stock | 8k | $11.87 | $94.5k | | 09/26/2019 |
| 09/26/2019 | KalVista Pharmaceuticals, Inc. | KALV | Purchase | Common Stock | 2k | $11.90 | $24.3k | | 09/26/2019 |
| 06/26/2019 | ACADIA PHARMACEUTICALS INC | ACAD | Grant | Stock Option (Right to Buy) | 22.5k | $25.24 | $567.9k | | 06/26/2019 |
| 04/22/2019 | KalVista Pharmaceuticals, Inc. | KALV | Grant | Director Stock Option (Right to Buy) | 14k | $26.40 | $369.6k | | 04/22/2019 |
| 06/06/2018 | ACADIA PHARMACEUTICALS INC | ACAD | Grant | | 15k | $17.52 | $262.8k | | 06/06/2018 |
| 03/02/2018 | ACADIA PHARMACEUTICALS INC | ACAD | Purchase | Common Stock | 3k | $22.52 | $67.6k | | 03/01/2018 |
| 03/01/2018 | ACADIA PHARMACEUTICALS INC | ACAD | Purchase | Common Stock | 2k | $23.02 | $46k | | 03/01/2018 |
| 03/01/2018 | ACADIA PHARMACEUTICALS INC | ACAD | Purchase | Common Stock | 3k | $24.09 | $72.3k | | 03/01/2018 |
| 03/01/2018 | ACADIA PHARMACEUTICALS INC | ACAD | Purchase | Common Stock | 2k | $24.52 | $49k | | 03/01/2018 |
| 06/10/2016 | ACADIA PHARMACEUTICALS INC | ACAD | Grant | Stock Option (right to buy) | 12.5k | $39.60 | $495k | | 06/10/2016 |
| 03/09/2012 | VIROPHARMA INC | VPHM | Payment of Exercise | Common Stock | 21.1k | $29.65 | $624.8k | | 03/09/2012 |
| 03/09/2012 | VIROPHARMA INC | VPHM | Exercise | Employee Stock Option (Right to Buy) | 6.6k | $15.24 | $100k | | 03/09/2012 |
| 03/09/2012 | VIROPHARMA INC | VPHM | Exercise | Employee Stock Option (Right to Buy) | 5k | $9.96 | $49.8k | | 03/09/2012 |
| 03/09/2012 | VIROPHARMA INC | VPHM | Exercise | Employee Stock Option (Right to Buy) | 5.6k | $13.50 | $75k | | 03/09/2012 |
| 03/09/2012 | VIROPHARMA INC | VPHM | Exercise | Employee Stock Option (Right to Buy) | 31.2k | $12.83 | $400k | | 03/09/2012 |
| 01/05/2011 | VIROPHARMA INC | VPHM | Grant | Employee Stock Option (Right to Buy) | 54.5k | $17.84 | $971.7k | | 01/05/2011 |
| 05/07/2010 | VIROPHARMA INC | VPHM | Purchase | common stock | 10k | $11.91 | $119.1k | | 05/06/2010 |
|